Skip to main content

Advertisement

Table 7 Compounds considered for the training set

From: Novel glitazones as PPARγ agonists: molecular design, synthesis, glucose uptake activity and 3D QSAR studies

Compound R′ Glucose uptake activity
lnGU Predicted activity Residual activity
CPD02 3.91 3.87 0.04
CPD03 4.39 4.36 0.03
CPD04 4.30 4.26 0.04
CPD05 4.20 4.15 0.05
CPD07 4.48 4.45 0.03
CPD08 4.50 4.40 0.10
CPD09 2.99 2.86 0.13
CPD10 3.73 3.64 0.09
CPD11 4.31 4.28 0.03
CPD12 4.27 4.23 0.04
CPD14 4.25 4.18 0.07
CPD15 3.81 3.78 0.03
CPD16 4.00 3.98 0.02
CPD17 3.56 3.49 0.07
CPD18 4.17 4.12 0.05
CPD19 4.50 4.48 0.02
CPD20 4.38 4.32 0.06
CPD21 4.44 4.45 0.01
CPD22 4.01 4.12 − 0.11
CPD23 3.69 3.61 0.08